Literature DB >> 16966439

Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.

R H Luong1, K E Baer, D M Craft, S N Ettinger, T J Scase, P J Bergman.   

Abstract

The prognosis of canine soft-tissue sarcomas (STS) has traditionally been based on histologic grading. We have recently demonstrated the prognostic value of cellular proliferation markers in canine STS. Another method of predicting the behavior of neoplasms is intratumoral microvessel density (IMD), which is a measure of tumor angiogenesis. The prognostic significance of IMD has been documented in many human neoplasms and in a limited number of canine and feline neoplasms. To evaluate the prognostic value of IMD in canine STS, we studied 57 STS and compared IMD with histologic features, histologic grade, cellular proliferation, metastatic propensity, and survival. Using immunohistochemistry, the STS were labeled with anti-factor VIII-related antigen (FVIII-RA) and anti-CD31 antibodies to determine 3 IMD parameters: mean microvessel density, high microvessel density, and microvessel area. Using FVIII-RA and CD31, increasing IMD was statistically associated with increasing histologic grade, necrosis scores, and mitotic scores. Higher FVIII-RA IMD values were significantly associated with higher median argyrophilic nucleolar organizing region (AgNOR) values (as previously investigated) and increased metastatic propensity. Fibrosarcomas appear to be the least vascularized of STS. There is no correlation between IMD and survival. Our results indicate that IMD is of prognostic value for histologic grade, histologic features, cellular proliferation (based on AgNOR), and metastatic propensity of canine STS, specifically when using FVIII-RA as the endothelial marker. Assessing histologic grading, cellular proliferation, and IMD of canine STS at the time of diagnosis could therefore provide better prognostic information for the veterinary clinician.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966439     DOI: 10.1354/vp.43-5-622

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  4 in total

1.  Feasibility of using gene expression analysis to study canine soft tissue sarcomas.

Authors:  Jennifer A Mahoney; Julie C Fisher; Stacey A Snyder; Marlene L Hauck
Journal:  Mamm Genome       Date:  2010-11-13       Impact factor: 2.957

2.  Correlation of pretreatment polarographically measured oxygen pressures with quantified contrast-enhanced power doppler ultrasonography in spontaneous canine tumors and their impact on outcome after radiation therapy.

Authors:  Carla Rohrer Bley; Dagmar Laluhova; Malgorzata Roos; Barbara Kaser-Hotz; Stefanie Ohlerth
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

3.  Subcutaneous soft tissue sarcoma with rhabdoid features in a dog.

Authors:  Ayako Sayama; Keiko Okado; Masako Imaoka; Yusuke Yokouchi; Toshimasa Jindo; Wataru Takasaki
Journal:  J Toxicol Pathol       Date:  2014-02-05       Impact factor: 1.628

4.  MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment.

Authors:  Pan Wang; Xinhua Song; Kirsten Utpatel; Runze Shang; Yoon Mee Yang; Meng Xu; Jie Zhang; Li Che; John Gordan; Antonio Cigliano; Ekihiro Seki; Matthias Evert; Diego F Calvisi; Xiaosong Hu; Xin Chen
Journal:  Cell Death Dis       Date:  2019-02-11       Impact factor: 9.685

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.